Tadalis Useful in PAH Treatment

Tadalis is the guaranteed and well known solution to treat the erectile dysfunction. Tadalis, a generic version of Cialis, is found to be effective in the treatment of pulmonary arterial hypertension (PAH). The new use of Tadalis was discovered when a patient suffering with erectile dysfunction found a relief even from the pulmonary arterial hypertension. Tadalis contains Tadalafil that is found be very effective in the treatment of pulmonary arterial hypertension. According to the research scientists Tadalis can give you a relief from the pulmonary arterial hypertension within a short span of time. The latest news is that the companies manufacturing the Tadalis are trying to get the approval from Food and Drug Administration (FDA) about the usage of Tadalis to treat pulmonary arterial hypertension.

Pulmonary arterial hypertension is the condition when the pulmonary artery gets the tension because of the high blood pressure. The pulmonary arteries are the major blood vessels that carry blood from the right side of the heart to the lungs. When pressure in the pulmonary circulation becomes abnormally elevated, it is referred to as a pulmonary artery hypertension. Emphysema, dermatomyositis, chronic obstructive pulmonary disease (COPD), failure of the left heart ventricle, human immunodeficiency virus (HIV), advanced liver disease (porto-pulmonary hypertension), and sarcoidosis are the causes of the pulmonary arterial hypertension. Sometimes it can even occur due to the side effects of some medicines like dexfenfluramine. The symptoms of pulmonary arterial hypertension shortness of breath, fatigue, non-productive cough, angina pectoris, fainting or syncope, peripheral edema (swelling of the limbs, especially around the ankles and feet), and rarely hemoptysis (coughing up blood).
Tadalis gives the men a capability to achieve the erection and allow him to hold the erection for the sufficient period of time during the sexual intercourse. Men also noted a relief from the pulmonary arterial hypertension when they took Tadalis for treating the erectile dysfunction. To confirm the usage of Tadalis for the pulmonary arterial hypertension, a study was conducted by the group of research workers. In the placebo controlled, randomised and double blind format study the 500 men and women suffering with pulmonary arterial hypertension participated. In the first week, all these individuals were given the low doses of Tadalis and then after the week were checked to know the changes. Only 20% individuals found the relief from the pulmonary arterial hypertension in the first week.

In the second week, the remaining 80% individuals were given the same doses of Tadalafil. It was observed that 25% individuals observed relief from the pulmonary arterial hypertension. For the remaining 55% individuals the dosage of the Tadalis was doubled for the duration of 2 weeks. When these individuals were checked, around 60% of the individuals were relieved from the pulmonary arterial hypertension. Thus, it was concluded from the study that 65% of the individuals from a group of 500 men and women found relief from pulmonary arterial hypertension with the help of Tadalis.

Tadalis treats the erectile dysfunction by relaxing the arteries in the penile region by releasing the nitric oxide. Same way the Tadalis relaxes the pulmonary arteries in the heart region and reduces the tension on them. As a result the pulmonary arteries get relaxed and the pressure on them is relieved. The individuals treated with Tadalis for sixteen weeks showed an enhanced quality of life, were able to exert themselves more, and testing showed that they improved their hemodynamic parameters with reference to the severity of the hypertension. Thus, the new use of Tadalis was discovered. As the manufacturers are trying to get the approval from FDA about the use of Tadalis as a treatment for pulmonary arterial hypertension, we need to wait for some time to use Tadalis as a treatment of pulmonary arterial hypertension along with the erectile dysfunction.